310 deaths from all causes, (including 11 762 vascular and 15 150 neoplastic deaths), and 39 018 first incident cardiovascular disease outcomes, including 12 090 stroke events, 14 539 myocardial infarction events, 7990 coronary disease events excluding myocardial infarction, 2711 heart failure events, and 1121 deaths from other cardiovascular diseases (appendix p 13).Table 1Study-level and participant-level characteristics of the contributing data sourcesERFCEPIC-CVDUK BiobankParticipants with resurveys of alcohol consumptionStudy level characteristicsLocation81 studies in 19 countries22 centres in 10 European countriesEngland, Scotland, and Wales37 studies in 15 countriesYears of recruitment1964–20081990–20022006–101964–2010Year of most recent endpoint follow-up2013200920162016Participant level characteristicsTotal participants356 81930 702358 83389 499Known current drinkers at baseline247 50426 036326 37271 011Weekly baseline alcohol consumption in current drinkers>0–≤25 g per week53 418 (22%)7906 (30%)39 641 (12%)12 301 (17% [11 g/week vs 36 g/week]‡)>25–≤50 g per week33 953 (14%)3704 (14%)39 334 (12%)8365 (12% [38 g/week vs 56 g/week]‡)>50–≤75 g per week26 656 (11%)2748 (11%)42 907 (13%)7322 (10% [63 g/week vs 80 g/week]‡)>75–≤100 g per week16 557 (7%)2446 (9%)36 780 (11%)6394 (9% [87 g/week vs 98 g/week]‡)>100–≤150 g per week36 236 (15%)2602 (10%)55 815 (17%)10 051 (14% [126 g/week vs 126 g/week]‡)>150–≤250 g per week31 645 (13%)3090 (12%)60 025 (18%)12 255 (17% [193 g/week vs 173
